Condition: Burkitt Lymphoma · Sponsor: French Africa Pediatric Oncology Group
This is the 4th LMB study by the French African Pediatric Oncology Group (GFAOP). The study hopes to be able to evaluate children earlier with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for the stage IV disease.
This description comes directly from the study's public registry record.
Chantal Ms BOUDA, Dr. · 00(226)70 10 01 30 · cgbouda@yahoo.fr
BRENDA MALLON, MSc PhD · 0033142115411 · brenda.mallon@gustaveroussy.fr
Always discuss trial participation with your own doctor first.
| Hopital Yalgado Ouedraogo | Ouagadougou, Burkina Faso | Recruiting |
| CHU de Treichville à ABIDJAN | Abidjan, Côte d’Ivoire | Recruiting |
| Cliniques Universitaires de Kinshasa | Kinshasa, Kinshasa City, Democratic Republic of the Congo | Recruiting |
| Cliniques Universitaires de Lubumbashi (CUL) | Lubumbashi, Democratic Republic of the Congo | Recruiting |
| HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona | Antananarivo, Madagascar | Recruiting |
| CHU Gabriel Touré (HGT) | Bamako, Mali | Recruiting |
| Hôpital Aristide Le Dantec | Dakar, Senegal | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04425421